EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Equal Treatment, Unequal Outcomes? Debunking the Racial Disparity in Renin Angiotensin Aldosterone System Inhibitor–Associated Reduction in Heart Failure Hospitalizations

Shana D R Littleton, David E Lanfear, Michael P Dorsch, Bin Liu, Jasmine A Luzum

Journal of Cardiac Failure · 2025

DOI: 10.1016/j.cardfail.2024.09.012 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Cardiac Failure, 2025. Verfasst von Shana D R Littleton und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Michigan College of Pharmacy, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Healthcare Disparities, Heart Failure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Renin angiotensin aldosterone system inhibitors (RAASi) are a mainstay treatment in patients with heart failure with reduced ejection fraction (HFrEF) in part to prevent hospitalizations. However, whether RAASi reduce the risk of hospitalization in Black patients is not entirely clear because enrollment of Black patients in previous clinical trials was low and a previous meta-analysis showed a significant racial disparity: reduction in hospitalizations with an RAASi in White patients but not Black patients. Previous studies relied on the use of self-identified race instead of genomic ancestry. Therefore, this study aimed to investigate the role of self-identified race and genomic ancestry in the racial disparity in RAASi-associated reductions in HFrEF hospitalizations. METHODS: The primary outcome was time to first heart failure hospitalization. Data from the Henry Ford Heart Failure Pharmacogenomic Registry (HFPGR) and the GUIDE-IT multi-center randomized control trial were analyzed with Cox proportional hazards models un/adjusted for clinical risk factors, death as a competing risk, and time-varying RAASi exposure. The proportion of Yoruba African ancestry was quantified. Analyses of self-identified race were performed in both the HFPGR and GUIDE-IT. Analysis of genomic ancestry was only performed in the HFPGR since this information was not available in GUIDE-IT. A fixed effect meta-analysis combined results of both the HFPGR and GUIDE-IT for race. RESULTS: The HFPGR had 1010 total HFrEF patients (Black = 509 and White = 501) with 852 having ancestry quantification (>80% Yoruba African Ancestry = 381 and 80% Yoruba African Ancestry = 0.93 [0.51-1.69], P = .80;

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsHealthcare DisparitiesHeart FailureHospitalizationRenin-Angiotensin SystemAgedFemaleHumansMaleMiddle AgedBlack or African AmericanRegistriesStroke VolumeTreatment OutcomeWhite

Substanzen

Angiotensin Receptor AntagonistsAngiotensin-Converting Enzyme Inhibitors

Autor:innen und Institutionen

  • University of Michigan College of Pharmacy, Ann Arbor, Michigan.
  • Henry Ford Health System, Detroit, Michigan.
  • University of Michigan College of Pharmacy, Ann Arbor, Michigan. Electronic address: jluzum@med.umich.edu.

Förderung

  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute
  • National Institutes of Health
  • American Heart Association
  • Agency for Healthcare Research and Quality

Zitieren

APA

Littleton, S. D. R., Lanfear, D. E., Dorsch, M. P., Liu, B., & Luzum, J. A. (2025). Equal Treatment, Unequal Outcomes? Debunking the Racial Disparity in Renin Angiotensin Aldosterone System Inhibitor–Associated Reduction in Heart Failure Hospitalizations. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2024.09.012

Vancouver

Littleton SDR, Lanfear DE, Dorsch MP, Liu B, Luzum JA. Equal Treatment, Unequal Outcomes? Debunking the Racial Disparity in Renin Angiotensin Aldosterone System Inhibitor–Associated Reduction in Heart Failure Hospitalizations. Journal of Cardiac Failure. 2025. doi:10.1016/j.cardfail.2024.09.012

BibTeX
@article{Littleton2025,
  author = {Littleton, Shana D R and Lanfear, David E and Dorsch, Michael P and Liu, Bin and Luzum, Jasmine A},
  title = {Equal Treatment, Unequal Outcomes? Debunking the Racial Disparity in Renin Angiotensin Aldosterone System Inhibitor–Associated Reduction in Heart Failure Hospitalizations},
  journal = {Journal of Cardiac Failure},
  year = {2025},
  doi = {10.1016/j.cardfail.2024.09.012}
}
Kostenlos starten →